Filing Details

Accession Number:
0001209191-21-033812
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-18 20:17:11
Reporting Period:
2021-05-18
Accepted Time:
2021-05-18 20:17:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831828 Vera Therapeutics Inc. VERA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1720685 Maha Katabi C/O Vera Therapeutics, Inc.
170 Harbor Way, 3Rd Floor
South San Francisco CA 94080
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-05-18 2,187,504 $0.00 2,187,504 No 4 C Indirect See footnote
Class A Common Stock Acquisiton 2021-05-18 727,272 $11.00 2,914,776 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Series C Preferred Stock Disposition 2021-05-18 2,187,504 $0.00 2,187,504 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
Footnotes
  1. The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date.
  2. The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy, Maha Katabi, and Michael F. Powell are the managing members of SM X and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her proportionate pecuniary interest therein.